Dr. Meredith McKean on mRNA Combined Immunotherapy for Melanoma – NBCLX

Research on a new treatment for melanoma, an aggressive type of skin cancer, is showing some encouraging signs. SCRI’s Director of Melanoma and Skin Cancer Research, Dr. Meredith McKean, joined NBCLX to the preliminary study’s significance in the field of cancer vaccine development. This is now a chance to redefine how melanoma and other cancers are treated, watch to learn more.